CLCSOTCPharmaceutical PreparationsFiscal year ends December 31
Cell Source, Inc.
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- $21.99M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Cell Source has not reported a dividend
No dividend per share appears in Cell Source's annual filings since fiscal 2012.